PXMP4: A Potential Drug Target and Biomarker (G11264)

Target Name: PXMP4

NCBI ID: G11264

PXMP4

PXMP4: A Potential Drug Target and Biomarker

Perspectives in Neuroscience

Purpose

PXMP4, short for protein X motif-containing protein 4, is a protein that has been identified as a potential drug target and biomarker. Its unique structure and various functions make it an attractive target for drug development. This article will discuss the properties of PXMP4, its potential as a drug target, and its potential as a biomarker for various neurological disorders.

Structure and Function

PXMP4 is a protein that is expressed in various tissues, including the brain. Its primary function is to regulate the activity of other proteins, particularly those involved in the development and maintenance of synapses. It does this by interacting with various protein partners, including the neurotransmitter acetylcholine.

PXMP4 is composed of 111 amino acid residues and has a molecular weight of 12.9 kDa. It has a unique structure that consists of a long N-terminus, a single transmembrane segment, and a C-terminus. The N-terminus of PXMP4 contains a protein-coding region that encodes the amino acids involved in the interaction with neurotransmitters.

The PXMP4 structure is important for its function in regulating neurotransmitter signaling. Its N-terminus contains a region that is highly conserved and is involved in the formation of a protein-protein interaction. This interaction is critical for the regulation of neurotransmitter signaling by ensuring that only the necessary amount of neurotransmitters are released at the right time.

Potential Drug Target

PXMP4 has been identified as a potential drug target due to its unique structure and its involvement in the regulation of neurotransmitter signaling. Its N-terminus, which is involved in protein-protein interaction, makes it an attractive target for small molecules that can modulate the interaction between PXMP4 and other proteins involved in neurotransmitter signaling.

One of the challenges in developing a drug target is ensuring that the drug does not have unintended consequences. PXMP4 is involved in the regulation of a wide range of neurotransmitters, including dopamine, serotonin, and GABA. Therefore, it is essential to ensure that the drug does not have a significant impact on these neurotransmitters.

Potential Biomarker

PXMP4 has also been identified as a potential biomarker for various neurological disorders. Its unique structure and its involvement in the regulation of neurotransmitter signaling make it an attractive target for diagnostic tools.

One of the challenges in developing a biomarker is ensuring that it is specific and sensitive. PXMP4 is involved in the regulation of a wide range of neurotransmitters, including dopamine, serotonin, and GABA. Therefore, it is essential to ensure that the biomarker is specific to these neurotransmitters and that it is sensitive enough to detect changes in neurotransmitter levels.

Conclusion

PXMP4 is a protein that has been identified as a potential drug target and biomarker. Its unique structure and its involvement in the regulation of neurotransmitter signaling make it an attractive target for drug development. Additionally, its potential as a biomarker for various neurological disorders makes it an attractive target for diagnostic tools. Further research is needed to determine its true potential and to develop safe and effective drugs that target PXMP4.

Protein Name: Peroxisomal Membrane Protein 4

The "PXMP4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PXMP4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets